| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/2014 | US8835466 Synthesis and uses of pyroglutamic acid derivatives |
| 09/16/2014 | US8835465 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 09/16/2014 | US8835464 Triazole compounds that modulate HSP90 activity |
| 09/16/2014 | US8835463 Compounds having analgesic and/or immunostimulant activity |
| 09/16/2014 | US8835461 Substituted 3-hydroxy-4-pyridone derivative |
| 09/16/2014 | US8835460 Sublingual fentanyl spray and methods of treating pain |
| 09/16/2014 | US8835459 Sublingual fentanyl spray |
| 09/16/2014 | US8835458 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells |
| 09/16/2014 | US8835456 NS5A inhibitors useful for treating HCV |
| 09/16/2014 | US8835455 Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt |
| 09/16/2014 | US8835454 Fused bicyclic diamine derivatives as HIV attachment inhibitors |
| 09/16/2014 | US8835453 Sustained release implant for granisetron |
| 09/16/2014 | US8835452 Polymorphic forms α, β and γ of rifaximin |
| 09/16/2014 | US8835451 Compounds |
| 09/16/2014 | US8835450 Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer |
| 09/16/2014 | US8835449 2-thiopyrimidinones |
| 09/16/2014 | US8835448 Methods and formulations for modulating lyn kinase activity and treating related disorders |
| 09/16/2014 | US8835447 Method for treating androgen receptor positive cancers |
| 09/16/2014 | US8835445 Dihydrofolate reductase inhibitors |
| 09/16/2014 | US8835443 Pyrimidine compound and medical use thereof |
| 09/16/2014 | US8835442 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2H-thiazolo [4,5-di pyrimidin-6-yl—and process for preparation thereof |
| 09/16/2014 | US8835441 Heterobicyclic metalloprotease inhibitors |
| 09/16/2014 | US8835440 Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD |
| 09/16/2014 | US8835439 Pharmaceutical composition containing (2R)-methyl-1-3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinylpiperazine L-malate for treatment of serotonin-related diseases |
| 09/16/2014 | US8835438 Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone |
| 09/16/2014 | US8835437 Piperidine/piperazine derivatives |
| 09/16/2014 | US8835436 Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same |
| 09/16/2014 | US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 09/16/2014 | US8835434 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 09/16/2014 | US8835433 Optically pure diastereomers of 10-Propargyl-10-deazaaminopterin and methods of using same for the treatment of cancer |
| 09/16/2014 | US8835432 Heterocyclic compounds and their uses |
| 09/16/2014 | US8835431 Kinase inhibitors |
| 09/16/2014 | US8835430 2,4-pyrimidinediamine compounds and their uses |
| 09/16/2014 | US8835429 Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses |
| 09/16/2014 | US8835428 Diacylglycerol acyltransferase inhibitors |
| 09/16/2014 | US8835426 Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| 09/16/2014 | US8835425 Use of selective GABA A α5 negative allosteric modulators for the treatment of central nervous system conditions |
| 09/16/2014 | US8835424 Selective agents for pain suppression |
| 09/16/2014 | US8835423 Azepine inhibitors of janus kinases |
| 09/16/2014 | US8835422 Substituted imidazoheterocycle derivatives |
| 09/16/2014 | US8835421 Benzimidazole linked pyrrolo[2,1-c[1,4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof |
| 09/16/2014 | US8835420 Azaindole derivatives |
| 09/16/2014 | US8835419 Substituted anilines as CCR(4) antagonists |
| 09/16/2014 | US8835418 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 09/16/2014 | US8835417 Crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)-(3-(4-(thiazole-2-carbonyl)piperazin-1-yl)azetidin-1-yl)methanone |
| 09/16/2014 | US8835415 Standardized composition, method of manufacture and use in the resolution of RNA virus infection |
| 09/16/2014 | US8835414 Treatment of vaginal atrophy in women with cardiovascular pathology risk |
| 09/16/2014 | US8835413 Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women |
| 09/16/2014 | US8835412 Isoxazolidine derivatives |
| 09/16/2014 | US8835410 Treatment of eyelid dermatitis |
| 09/16/2014 | US8835408 Hemostatic compositions and uses therefor |
| 09/16/2014 | US8835407 Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
| 09/16/2014 | US8835406 Treatment of reynaud's disease |
| 09/16/2014 | US8835405 Inhibiting arthritis via injection of synergistic combination of hyaluronic acid and vitamin C and/or vitamin E |
| 09/16/2014 | US8835403 Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same |
| 09/16/2014 | US8835401 Treatment of cancer by inhibition of IGFBPs and clusterin |
| 09/16/2014 | US8835397 Macrocyclic lactone tablet formulation |
| 09/16/2014 | US8835396 Method and compositions for improving pulmonary hypertension |
| 09/16/2014 | US8835394 Treatment for basal cell carcinoma |
| 09/16/2014 | US8835391 Alpha B-crystallin as a therapy for multiple sclerosis |
| 09/16/2014 | US8835390 Modulation of osteoclast differentiation |
| 09/16/2014 | US8835389 Use of calcitonin for the treatment of RA |
| 09/16/2014 | US8835376 Process for making particles for delivery of drug nanoparticles |
| 09/16/2014 | US8835164 Cell line stably expressing mutated oncoprotein E6 and method of screening anticancer compound of uterine cervical cancer using the same |
| 09/16/2014 | US8835134 Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof |
| 09/16/2014 | US8834943 Compositions containing amines and use thereof |
| 09/16/2014 | US8834940 Compositions and method for hair loss prevention |
| 09/16/2014 | US8834938 Use of arsenic for cancer therapy protection |
| 09/16/2014 | US8834931 Dry powder formulation containing tiotropium for inhalation |
| 09/16/2014 | US8834930 Pulmonary delivery of a fluoroquinolone |
| 09/16/2014 | US8834925 Tamper resistant dosage forms |
| 09/16/2014 | US8834924 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| 09/16/2014 | US8834923 Slow-release composition, method for the preparation thereof, and use thereof |
| 09/16/2014 | US8834921 Sustained-release liposomal anesthetic compositions |
| 09/16/2014 | US8834916 Apparatus and method for removing epithelium from the cornea |
| 09/16/2014 | US8834913 Medical implants and methods of making medical implants |
| 09/16/2014 | US8834907 Active nanocomposite materials and production method thereof |
| 09/16/2014 | US8834905 Wound dressing compositions |
| 09/16/2014 | US8834902 Biodegradable supporting device |
| 09/16/2014 | US8834900 Combination motif immune stimulatory oligonucleotides with improved activity |
| 09/16/2014 | US8834887 Drug for suppressing pathogen occurring in vivo |
| 09/16/2014 | US8834884 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 09/16/2014 | US8834868 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
| 09/16/2014 | US8834861 Polycarbonates for delivery of drugs and methods of preparation thereof |
| 09/16/2014 | US8834858 Treatment for dyslipidemia |
| 09/16/2014 | US8834857 Deodorizing and skin cleaning |
| 09/16/2014 | US8834852 Composition for oral cavity |
| 09/16/2014 | US8834544 Photodynamic therapy for tumors with localized delivery |
| 09/16/2014 | US8834447 Transdermal drug delivery patch and method of controlling drug release of the same by near-IR |
| 09/16/2014 | CA2825308C Pyrazolopyrimidone compound for treating erectile dysfunction |
| 09/16/2014 | CA2787097C Low viscosity liquid polymeric delivery system |
| 09/16/2014 | CA2781066C Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| 09/16/2014 | CA2778317C Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 09/16/2014 | CA2777532C Stable rasagiline composition |
| 09/16/2014 | CA2765409C Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 09/16/2014 | CA2753641C Bendamustine cyclopolysaccharide compositions |
| 09/16/2014 | CA2752569C .delta.-amino acid as an exercise function-improving agent |
| 09/16/2014 | CA2750864C Bis-aryl amide compounds and methods of use |
| 09/16/2014 | CA2727830C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 09/16/2014 | CA2677842C Pharmaceutical composition comprising microparticle oily suspension |